[ad_1]
China News Service, December 10, according to a full report, according to real-time statistics from Johns Hopkins University in the United States, at 7:28 a.m. on December 10 Beijing time, a total of more than 68.79 million new confirmed cases of crowns worldwide and a total of deaths. There are almost 1.57 million cases. To contain the epidemic, many countries have accelerated their new crown vaccination plans.
USA May Approve Emergency Use of Pfizer Vaccine
170,000 doses distributed in New York
Today, the United States remains the country with the worst epidemic of new crowns in the world, with a total of 15.35 million confirmed cases and a total of 288,000 deaths, so it is urgent to stop the spread of the epidemic.
At 9 local time, New York Governor Cuomo said that the state will receive the first batch of new corona vaccines starting this weekend and will be provided to high-risk medical workers, nursing home residents. and its staff.
Cuomo said the first shipment of 170,000 doses of the Pfizer vaccine will be distributed according to the number of nursing home residents and healthcare workers in each region. Among them, New York City, the most affected state in the state, will receive about 72,000 doses of vaccine.
Cuomo also said that, referring to federal guidelines, once the first batch of vaccines is complete, New York State’s next goal is to vaccinate teachers, police and other front-line workers and people with a history of diseases. He said ordinary people may not have a chance to get vaccinated until “early February” next year at the earliest.
On the other hand, the United States Food and Drug Administration (FDA) announced on the 8th that the United States did not raise new questions about the safety and efficacy of Pfizer’s new corona vaccine, clarifying the authorization of emergency use of this new vaccine against corona pneumonia. obstacle. The FDA advisory committee is expected to hold a meeting on the 10th local time to confirm whether the emergency use authorization for the Pfizer vaccine is approved.
On December 8 local time, the UK began vaccinating the new corona vaccine.
Canada approves first new corona vaccine
Two British doctors have allergic symptoms
At the eighth local time, the UK officially launched Pfizer’s new corona vaccination job. According to British media reports, two British health workers developed allergic symptoms after vaccination. In light of this, the UK drug regulatory agency recommends that people with a history of severe allergies not receive the new corona vaccine from Pfizer / BioNTech.
Britain’s drug regulatory agency said it will seek further information and give priority to investigating the matter. Pfizer and BioNTech said they are supporting the research. Pfizer has previously stated that no person with a history of serious adverse allergic reactions to the vaccine or vaccine components participated in subsequent trials.
Adam Finn, professor of pediatric medicine at the University of Bristol, said: “Serious allergic reactions to vaccines are not common, but the personnel responsible for vaccination have been trained and equipped to deal with this situation.”
In addition to the UK, the Canadian health department also approved the use of the new corona vaccine on the 9th. The Associated Press reported that the Canadian government has purchased 20 million doses of the Pfizer vaccine and may choose to purchase an additional 56 million doses. . Canada is expected to obtain up to 249,000 doses of vaccine and 4 million doses by March 2021 in December.
At the same time, Health Canada is reviewing three other candidate vaccines, including the one developed by Moderna in the United States.
On December 9 local time, to prevent further spread of the new corona pneumonia epidemic, a library in Tokyo, Japan, used ultraviolet light to disinfect borrowed and returned books.
Japan and South Korea plan to introduce new corona vaccines from abroad
The timing of mass vaccination has not yet been determined.
The South Korean government recently declared that it will secure around 34 million doses of the new crown vaccine from four pharmaceutical companies, including AstraZeneca, Janssen, Modena and Pfizer. The vaccine is expected to enter South Korea in phases from February to March 2021, but the priority of which products to import and when to begin vaccination has not been determined.
Pfizer Pharmaceuticals and the Japanese government have reached a basic agreement on the supply of 120 million doses of vaccines in the first half of 2021, but they will undergo clinical trials and review procedures in Japan. Vaccination is expected to start around March 2021 at the earliest.
In addition, the British pharmaceutical company AstraZeneca has also reached an agreement with Japan to provide 120 million doses of vaccines and is implementing clinical trials. The American biotech company Modena also reportedly signed a contract with the Japanese government to provide 50 million doses of the vaccine, but clinical trials are still in the preparation stage. Among the Japanese domestic manufacturers, the pharmaceutical innovation company “AnGes” has also started clinical trials, and other companies like Shiono Yoshino Pharmaceutical also plan to start trials in the near future.
